Full Event Guide
Browse the 2024 Event Guide to Discover:
18+ expert speakers who discussed the latest advancements in allo therapies
Sessions which discussed CAR-T, γδT, NK, iPSCs and more
European Regulatory and Investment Panel Discussions
Session details for the 15+ hours of allogeneic content!
![Screenshot 2024-01-17 115837 Screenshot 2024-01-17 115837](https://allogeneic-cell-therapies-europe.com/wp-content/uploads/sites/632/2024/01/Screenshot-2024-01-17-115837.png)
*Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
Companies in the 2024 Programme Included:
![Screenshot 2023-10-16 114926 Cellectis Logo](https://allogeneic-cell-therapies-europe.com/wp-content/uploads/sites/632/2023/10/Screenshot-2023-10-16-114926.jpg)
![Screenshot 2023-10-16 115001 Caribou Biosciences Logo](https://allogeneic-cell-therapies-europe.com/wp-content/uploads/sites/632/2023/10/Screenshot-2023-10-16-115001.jpg)
![Screenshot 2023-10-16 115022 PDC* Line Pharma Logo](https://allogeneic-cell-therapies-europe.com/wp-content/uploads/sites/632/2023/10/Screenshot-2023-10-16-115022.jpg)
![Screenshot 2023-10-16 115117 Leucid Logo](https://allogeneic-cell-therapies-europe.com/wp-content/uploads/sites/632/2023/10/Screenshot-2023-10-16-115117.jpg)
"I loved the presentations, and the ideas that were raised. This was a great opportunity to discuss many challenges, highlighting the real dilemmas in the field."
– Senior Scientist, Immatics Biotechnologies, Past Attendee